Site icon

Lateral Lumbar Interbody Fusion Market Foreseen to Grow Exponentially by 2024

Hands with protective gloves fills syringe with vaccine. Hands of doctor in medical gloves injecting vaccine to a child patient. Doctor giving muscular injection to little child in arm. Vaccination healthcare concept. Selective focus on syringe and vial.

Lateral lumbar interbody fusion (LLIF) is a minimally invasive technique and is in demand for surgical spinal fusion procedure. LLIF is an effective and safe surgical procedure that makes post-operative recovery quicker and less painful. The incision is made from the side through psoas muscle that allows surgeons to access more surface area with less damage to the tissue and reduced blood loss. Lateral lumbar interbody fusion is a surgical procedure used to treat specific types of disorders of lumbar spine, such as degenerative disc disease, low grade spondylolisthesis, degenerative scoliosis (asymmetric disc degeneration) and deformity, and some recurrent lumbar herniated disc and lumbar stenosis. Developments in magnification and illumination associated with surgical instrumentation have led to increased applicability of minimally invasive technique for spinal fusion. High device cost and various procedure levels are likely to boost the growth of the market.

Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19367

The minimally invasive lateral lumbar interbody fusion has certain advantages such as enhanced spine alignment and easier spine access in several cases such as degenerative diseases and correction in sagittal and coronal deformities. Large number of surgeons prefer this procedure, as it results in less blood loss and lower damage to the tissues around the surgical area. Reduced time for operation and length of hospital stay, greater fusion, and lesser infection rates are the other advantages of this procedure. Increased incidence of degenerative diseases and rising prevalence of lower back pain in the population above 45 years drive the global lateral lumbar interbody fusion market. Higher visualization resulting in easy and precise operation with less tissue sparing practice are other factors that propel the global lateral lumbar interbody fusion market. However, high cost of operation and risks associated with lateral lumbar interbody fusion such as psoas muscles or neural network injury and bone graft fusion complication restrain the market.

The global lateral lumbar interbody fusion market has been segmented based on product type, end-user, and region. In terms of product type, the market has been classified into instruments or systems, implants, and supporting devices. The instruments or systems are based on extreme lateral lumbar interbody fusion or direct lateral lumbar interbody fusion (XLLIF/ DLLIF). Based on end-user, the global lateral lumbar interbody fusion market has been segmented into hospitals and ambulatory surgical centers (ASC).

Request for Analysis of COVID19 Impact on Lateral Lumbar Interbody Fusion Markethttps://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=19367

Superior technological advancements present significant opportunity in the global lateral lumbar interbody fusion market. Major market players are coming up with cutting edge technology. Amedica Corporation has introduced silicon nitride implants instead of PEEK and titanium that have superior osteointegration and artifact-free imaging. Several system and implant manufacturing companies for lateral lumbar interbody fusion procedure are offering pre-operative and post-operative care for patients, thereby extending their business as health solution providers. Furthermore, complications associated with traditional open surgery techniques of midline spinal fusion have led to increase in preference for interbody fusion technique, which in turn augments the global lateral lumbar interbody fusion market. Increasing focus on discovery of new techniques in instruments, advanced research in generating durable implants with lower likelihood of rejection, and invention of effective means for supporting devices are expected to steer the growth of the global lateral lumbar interbody fusion market.

In terms of region, the global lateral lumbar interbody fusion market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global lateral lumbar interbody fusion market owing to factors such as new and technologically advanced products being introduced in the market, significant investments in research and development of advanced products, and increasing demand from patients for better health care facilities.

Purchase Lateral Lumbar Interbody Fusion Market Reporthttps://www.transparencymarketresearch.com/checkout.php?rep_id=19367&ltype=S

Key players in the global lateral lumbar interbody fusion market are DePuy Synthes, NuVasive, Inc., Stryker Corporation, Smith & Nephew, Medtronic, Paradigm Spine, and Alphatec Spine.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad-hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

Read More Reports: http://www.prnewswire.com/news-releases/unhealthy-lifestyle-choices-and-disturbed-work-life-balance-to-lead-increased-sales-of-antihypertensive-drugs-market-valuation-to-rise-up-to-us33-9-bn-by-2027–finds-tmr-301021392.html

 

 

Exit mobile version